EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Controversies in NEN : An ENETS position statement on the diagnosis and treatment of mixed neuroendocrine/non‐neuroendocrine neoplasms of the digestive system

Francesca Spada iD, Atsuko Kasajima iD, Louis de Mestier iD, Tu Vinh Luong iD, Ilaria Marinoni iD, Massimo Milione iD, Anguraj Sadanandam iD, Ernst Jan Speel iD, Anna Koumarianou iD, Damiano Caruso iD, Andreas Pascher iD, Halfdan Sorbye iD

Journal of Neuroendocrinology · 2026-11 · 38 (11)

DOI: 10.1111/jne.70306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neuroendocrinology, online erschienen am 09.11.2026. Verfasst von Francesca Spada und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, IRCCS, ENETS and EURACAN Center of Excellence, Milan, Italy. Hauptthemen laut MEDLINE: Neuroendocrine Tumors, Digestive System Neoplasms. Die Arbeit nennt 63 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mixed neuroendocrine/non‐neuroendocrine neoplasms (MiNEN) of the digestive system are rare epithelial malignancies characterised by the coexistence of neuroendocrine and non‐neuroendocrine neoplasm components within the same lesion, where each component must account for at least 30% of the total tumour cell population. Despite growing recognition, MiNEN remain diagnostically and therapeutically challenging because of marked morphological heterogeneity, biological plasticity, and limited evidence guiding management. Recent molecular studies support a common clonal origin with subsequent divergent differentiation, although the mechanisms underlying progression and treatment resistance remain incompletely understood. This ENETS position statement summarises current evidence and expert opinion regarding the diagnosis and treatment of digestive MiNEN, focusing on major controversies in pathology, molecular biology, imaging, and management. Key diagnostic issues include the arbitrary 30% cutoff defining MiNEN, sampling limitations in biopsy specimens, intra‐tumoural heterogeneity, and the distinction between amphicrine and collision neoplasms. Molecular profiling increasingly demonstrates shared genomic alterations between distinct components and may identify potentially actionable targets, including high level of microsatellite instability (MSI‐high) or deficient mismatch repair (dMMR) and V‐RAF murine sarcoma viral oncogene homolog B1 ( BRAF ) alterations in selected cases. Clinical management should be individualised according to anatomical site, stage, differentiation and proliferation of each component, and the histology of metastatic disease when available. Surgery is the main potentially curative approach for localised resectable disease. Perioperative and metastatic systemic treatments are extrapolated predominantly from site‐specific adenocarcinoma and poorly differentiated neuroendocrine carcinoma (NEC) practice; no regimen has been prospectively established as superior specifically for MiNEN. Given the rarity and complexity of MiNEN, multidisciplinary management in expert centres, centralised pathological review, and international collaborative registries are essential to improve diagnostic standardisation and optimise treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neuroendocrine TumorsDigestive System NeoplasmsHumans

Stichwörter der Autor:innen

MiNENNENsgastro‐entero‐pancreaticmixed neuroendocrine/non‐neuroendocrineposition statement

Autor:innen und Institutionen

  • Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, IEO, IRCCS, ENETS and EURACAN Center of Excellence, Milan, Italy.
  • Department of Pathology, TUM School of Medicine and Health, Technical University Munich, Munich, Germany.
  • Department of Pancreatology and Digestive Oncology, Beaujon Hospital (APHP.Nord), Université Paris Cité, Clichy, France.
  • Department of Cellular Pathology, Royal Free London NHS Foundation Trust, London, UK.
  • Institute of Tissue Medicine and Pathology, University of Bern, Bern, Switzerland.
  • Department of Pathology, Azienda Socio-Sanitaria Territoriale di Cremona (ASST), Cremona, Italy.

ORCID-Profile: Francesca Spada, Atsuko Kasajima, Louis de Mestier, Tu Vinh Luong, Ilaria Marinoni, Massimo Milione, Anguraj Sadanandam, Ernst Jan Speel, Anna Koumarianou, Damiano Caruso, Andreas Pascher, Halfdan Sorbye

Zitieren

APA

Spada, F., Kasajima, A., de Mestier, L., Luong, T. V., Marinoni, I., Milione, M., Sadanandam, A., Speel, E. J., Koumarianou, A., Caruso, D., Pascher, A., & Sorbye, H. (2026). Controversies in NEN : An ENETS position statement on the diagnosis and treatment of mixed neuroendocrine/non‐neuroendocrine neoplasms of the digestive system. Journal of Neuroendocrinology, 38(11). https://doi.org/10.1111/jne.70306

Vancouver

Spada F, Kasajima A, de Mestier L, Luong TV, Marinoni I, Milione M, et al. Controversies in NEN : An ENETS position statement on the diagnosis and treatment of mixed neuroendocrine/non‐neuroendocrine neoplasms of the digestive system. Journal of Neuroendocrinology. 2026;38(11). doi:10.1111/jne.70306

BibTeX
@article{Spada2026,
  author = {Spada, Francesca and Kasajima, Atsuko and de Mestier, Louis and Luong, Tu Vinh and Marinoni, Ilaria and Milione, Massimo and Sadanandam, Anguraj and Speel, Ernst Jan and Koumarianou, Anna and Caruso, Damiano and Pascher, Andreas and Sorbye, Halfdan},
  title = {Controversies in NEN : An ENETS position statement on the diagnosis and treatment of mixed neuroendocrine/non‐neuroendocrine neoplasms of the digestive system},
  journal = {Journal of Neuroendocrinology},
  year = {2026},
  volume = {38},
  number = {11},
  doi = {10.1111/jne.70306}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche